Clinically relevant interpretation of genotype and relationship to plasma drug concentrations for resistance to saquinavir-ritonavir in human immunodeficiency virus type 1 protease inhibitor-experienced patientsMARCELIN, Anne-Geneviève; DALBAN, Cécile; COSTAGLIOLA, Dominique et al.Antimicrobial agents and chemotherapy. 2004, Vol 48, Num 12, pp 4687-4692, issn 0066-4804, 6 p.Article

HIV and antiretroviral drug distribution in plasma and fat tissue of HIV-infected patients with lipodystrophyDUPIN, Nicolas; BUFFET, Marc; MARCELIN, Anne-Geneviève et al.AIDS (London). 2002, Vol 16, Num 18, pp 2419-2424, issn 0269-9370, 6 p.Article

High indinavir plasma concentrations in HIV-positive patients co-infected with hepatitis B or C virus treated with low doses of indinavir and ritonavir (400/100 mg twice a day) plus two nucleoside reverse transcriptase inhibitorsBOSSI, Philippe; PEYTAVIN, Gilles; LAMOTTE, Claire et al.AIDS (London). 2003, Vol 17, Num 7, pp 1108-1110, issn 0269-9370, 3 p.Article

Phenotypic or genotypic resistance testing for choosing antiretroviral therapy after treatment failure: a randomized trialMEYNARD, Jean-Luc; VRAY, Muriel; BRUN-VEZINET, Francoise et al.AIDS (London). 2002, Vol 16, Num 5, pp 727-736, issn 0269-9370Article

Virological and pharmacological parameters predicting the response to lopinavir-ritonavir in heavily protease inhibitor-experienced patientsMARCELIN, Anne-Geneviève; COHEN-CODAR, Isabelle; PEIGUE-LAFEUILLE, Hélène et al.Antimicrobial agents and chemotherapy. 2005, Vol 49, Num 5, pp 1720-1726, issn 0066-4804, 7 p.Article

Once-daily dosing of saquinavir soft-gel capsules and ritonavir combination in HIV-1-infected patients (IMEA015 study)LAMOTTE, Claire; LANDMAN, Roland; FARINOTTI, Robert et al.Antiviral therapy (London). 2004, Vol 9, Num 2, pp 247-256, issn 1359-6535, 10 p.Article

Resistance profiles observed in virological failures after 24 weeks of amprenavir/ritonavir containing regimen in protease inhibitor experienced patientsMARCELIN, Anne-Geneviève; AFFOLABI, Dissou; COSTAGLIOLA, Dominique et al.Journal of medical virology. 2004, Vol 74, Num 1, pp 16-20, issn 0146-6615, 5 p.Article

Efficacy of a twice-daily antiretroviral regimen containing 100 mg ritonavir/400 mg indinavir in HIV-infected patientsGHOSN, Jade; LAMOTTE, Claire; KATLAMA, Christine et al.AIDS (London). 2003, Vol 17, Num 2, pp 209-214, issn 0269-9370, 6 p.Article

Genotypic inhibitory quotient as predictor of virological response to ritonavir-amprenavir in human immunodeficiency virus type 1 protease inhibitor-experienced patientsMARCELIN, Anne-Geneviève; LAMOTTE, Claire; BRICAIRE, Francois et al.Antimicrobial agents and chemotherapy. 2003, Vol 47, Num 2, pp 594-600, issn 0066-4804, 7 p.Article

Amprenavir inhibitory quotient and virological response in human immunodeficiency virus-infected patients on an amprenavir-containing salvage regimen without or with ritonavirDUVAL, Xavier; LAMOTTE, Claire; RACE, Ester et al.Antimicrobial agents and chemotherapy. 2002, Vol 46, Num 2, pp 570-574, issn 0066-4804Article